Clinical trials
Coronary Artery Bypass Surgery clinical trials
Below are recruiting coronary artery bypass surgery clinical trials, each written for real people, not researchers. We’re tracking 153 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07276282RecruitingPhase 3
Ziltivekimab for heart attack patients with artery plaque
This trial tests a new drug called Ziltivekimab to see if it can reduce plaque buildup in the heart arteries after a heart attack. It may help prevent future heart problems by targeting inflammation.
BernAges 18 years+ - NCT06857838Recruiting
Bypass surgery for symptomatic myocardial bridge
This trial tests whether bypass surgery is effective for people with a myocardial bridge (a heart muscle that arches over an artery) that still causes symptoms despite medication. It aims to see if surgery can improve symptoms and outcomes.
Xi'an, ShaanxiAges 18–80 - NCT05891145Recruiting
Remimazolam to prevent irregular heartbeat after heart surgery
This trial tests whether a medication called remimazolam can help prevent atrial fibrillation—a common, irregular heart rhythm that can happen after surgery. It focuses on people having a specific planned type of heart bypass surgery and checks if the study medication reduces postoperative rhythm problems.
Yangzhou, JiangsuAges 50–70 - NCT07871188Recruiting
Blood pressure swings and recovery after heart bypass surgery
This study looks at how changes in blood pressure during heart bypass surgery relate to how quickly the body clears lactic acid afterwards, which is a sign of recovery. It may help doctors understand recovery patterns after surgery.
GaziantepAges 18–80 - NCT07725887Recruiting
Structured physical therapy for high-risk heart bypass patients
This trial tests a structured physical therapy program for patients at high risk who are getting heart bypass surgery. The therapy is done in the hospital before and after surgery to help you recover better.
Istanbul, EyupsultanAges 18–90 - NCT07658521Enrolling by invitation
Nerve blocks for pain after heart bypass surgery
This study tests whether adding two numbing injections (nerve blocks) to standard care provides better pain relief after heart bypass surgery. It is for adults having planned surgery and compares pain scores and recovery.
Cairo, Cairo GovernorateAges 18–75 - NCT07528482Recruiting
Reflexology and cold therapy for chest tube removal pain
This study tests whether foot massage (reflexology) and cold application can reduce pain when chest tubes are removed after heart bypass surgery. Researchers want to see if these complementary techniques help manage discomfort during this procedure.
AnkaraAges 18 years+ - NCT06258681Recruiting
Breathing exercise device for recovery after heart surgery
This trial tests a new breathing exercise device designed to help your lungs recover after heart surgery. It may make your breathing easier and speed up your return to daily activities.
Istanbul, IstanbulAges 40–65 - NCT07380854Recruiting
Thyroid Hormone After Heart Bypass for Mild Underactive Thyroid
This study looks at whether giving thyroid hormone replacement to people with mild underactive thyroid (subclinical hypothyroidism) after heart bypass surgery improves their recovery. It is for adults who are scheduled for bypass surgery and have not recently used thyroid or anti-thyroid medications.
Seongnam-siAges 19–90 - NCT07265349RecruitingPhase 1/Phase 2
Stem cells plus bypass surgery for chronic heart failure
This trial tests whether injecting stem cells from umbilical cord tissue into the heart muscle during bypass surgery can improve heart function in people with chronic heart failure. It is for patients who are already scheduled for bypass surgery and have a weakened heart pump (LVEF between 21% and 40%).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07035171Recruiting
Pre-surgery exercise for heart bypass patients
This study tests whether starting a supervised exercise program before your first heart bypass surgery (CABG) is possible and helpful. If you are waiting for elective CABG and speak Danish, you may be able to join a prehabilitation program to get stronger before your operation.
CopenhagenAges 18 years+ - NCT06977230Recruiting
Arm-cuff protection before heart bypass in diabetes
This study tests whether a simple arm-cuff procedure done before heart bypass surgery can help protect the heart in people with type 2 diabetes. The goal is to see if this technique reduces complications during and after the operation.
MuğlaAges 45–85 - NCT06656117Enrolling by invitation
Elliptical vs. resistance training for heart bypass recovery
This study compares elliptical training with resistance training to see which better improves heart and lung function in patients who have had coronary artery bypass grafting (CABG). It aims to help you recover more fully during phase III cardiac rehab.
Sialkot, Punjab ProvinceAges 45–55 - NCT01932411Recruiting
Review of heart surgery outcomes at UC Davis
This study looks back at how people did after heart (cardiovascular) surgery at UC Davis Medical Center. It may help doctors understand what factors are linked to better or worse outcomes.
Sacramento, CaliforniaAges 18 years+ - NCT05230446Recruiting
Testing full stent treatment for heart artery blockages
This study looks at how well doctors can treat multiple blocked heart arteries using a specific drug-eluting stent, aiming to fully open them. It may help patients whose blockage pattern fits the study, but it does not include certain high-risk or special cases.
Rotterdam, South HollandAges 18–85 - NCT07830719RecruitingPhase 2
Study of a new drug for heart disease and inflammation
This study tests a new medicine called YMI024 for people with stable coronary artery disease (blockages in heart arteries) and higher than normal levels of inflammation. The drug aims to reduce inflammation and may lower the risk of future heart problems.
Adelaide, South AustraliaAges 18–80 - NCT07753200RecruitingPhase 4
Comparing two blood thinners for atrial fibrillation and heart disease
This study compares two blood-thinning medicines, edoxaban and apixaban, to see which one is better at preventing strokes and bleeding in people who have both atrial fibrillation and coronary artery disease. If you're eligible, you may receive one of these standard treatments, and the trial could help find the safer option.
SeoulAges 19 years+ - NCT07368933Recruiting
A drug-coated balloon for heart artery blockages
This trial tests a balloon coated with two drugs to treat narrowed or re-narrowed arteries in the heart. It may help people with chest pain or recent mild heart attacks who need a procedure to open a blockage.
BarcelonaAges 18 years+ - NCT07254572RecruitingPhase 4
Comparing diabetes drugs for heart health in prediabetes
This trial tests whether certain diabetes medications can help prevent worsening of heart disease in people who have prediabetes (higher than normal blood sugar, but not yet diabetes). It may be a good fit if you have known coronary artery disease and prediabetes.
WarsawAges 18–80 - NCT03378934RecruitingPhase 4
Berberine after stent placement to reduce blood-platelet effects
This trial studies whether berberine changes how strongly your platelets “stick together” after a coronary stent. It may help reduce risk related to clotting while you continue standard heart medicines (aspirin and clopidogrel).
Beijing, Beijing MunicipalityAges 18–70 - NCT05650411Recruiting
Test new drug-eluting stent with less blood thinner
This study compares a new type of “drug-eluting” stent (a tiny scaffold that slowly releases medicine) and a single blood-thinner plan versus the usual two-drug blood thinner plan after stent placement in the left main coronary artery. It aims to see if the simpler plan can work while keeping the stent safe.
Zurich, Canton of ZurichAges 18 years+ - NCT07405671RecruitingPhase 4
Flecainide safety for heart patients with atrial fibrillation
This trial tests a heart rhythm drug called flecainide to see if it is safe for people who have both atrial fibrillation (an irregular heartbeat) and coronary artery disease (narrowed heart blood vessels). Participation could help doctors decide if this drug is a good treatment option for you.
AalstAges 18 years+ - NCT07277686Recruiting
AI face scan for hidden heart disease in high-risk people
This trial tests whether an AI system can detect signs of coronary artery disease (blockages in heart arteries) by analyzing a photo of your face. It may help identify people in the community who need further heart testing.
Zhoukou, HenanAges 18 years+ - NCT07094087RecruitingPhase 3
Blood clotting medicine for heart surgery bleeding
This trial tests a medicine called 4F-PCC to stop bleeding during complex heart surgery that uses a heart-lung machine. It could help people who have bleeding problems after the surgery.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Coronary Artery Bypass Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for coronary artery bypass surgery?
- Yes. Clin2 currently lists 153 recruiting coronary artery bypass surgery studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coronary artery bypass surgery trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coronary artery bypass surgery trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.